Business Description
Oncolys BioPharma is a Japanese biopharmaceutical company founded in 2004 and based in Minato, Japan, focused on developing treatments for cancer and other serious diseases across Japan, the United States, and Asia. Its most advanced program is Telomelysin, a virus-based cancer therapy currently in clinical trials for gastric, esophageal, and liver cancers. The company is also advancing treatments for neurological conditions such as ALS and supranuclear palsy, as well as early-stage programs targeting pancreatic cancer and viral infections. In addition, Oncolys is developing TelomeScan, a tool designed to help detect cancer cells more accurately.
